Penumbra, Inc. (NYSE:PEN) Shares Sold by State of New Jersey Common Pension Fund D

State of New Jersey Common Pension Fund D trimmed its stake in shares of Penumbra, Inc. (NYSE:PENFree Report) by 3.1% during the third quarter, HoldingsChannel reports. The fund owned 20,733 shares of the company’s stock after selling 660 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Penumbra were worth $5,016,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Hollencrest Capital Management acquired a new position in shares of Penumbra in the second quarter worth about $25,000. Captrust Financial Advisors boosted its holdings in shares of Penumbra by 44.1% in the second quarter. Captrust Financial Advisors now owns 219 shares of the company’s stock worth $27,000 after buying an additional 67 shares during the period. Altshuler Shaham Ltd acquired a new position in shares of Penumbra in the fourth quarter worth about $27,000. Pinebridge Investments L.P. acquired a new position in shares of Penumbra in the second quarter worth about $30,000. Finally, Optimum Investment Advisors acquired a new position in shares of Penumbra in the second quarter worth about $34,000. Institutional investors and hedge funds own 88.18% of the company’s stock.

Analyst Upgrades and Downgrades

PEN has been the subject of several recent analyst reports. Morgan Stanley decreased their target price on shares of Penumbra from $265.00 to $240.00 and set an “equal weight” rating for the company in a report on Friday, November 3rd. Truist Financial raised their price target on shares of Penumbra from $265.00 to $295.00 and gave the stock a “buy” rating in a report on Friday, December 22nd. Royal Bank of Canada raised their price target on shares of Penumbra from $248.00 to $280.00 and gave the stock an “outperform” rating in a report on Thursday, January 11th. Piper Sandler decreased their price target on shares of Penumbra from $335.00 to $250.00 and set an “overweight” rating for the company in a report on Friday, November 3rd. Finally, TheStreet upgraded shares of Penumbra from a “d+” rating to a “c-” rating in a report on Friday, January 12th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $307.25.

Check Out Our Latest Stock Report on PEN

Penumbra Trading Down 1.2 %

NYSE:PEN opened at $269.89 on Tuesday. Penumbra, Inc. has a 12 month low of $180.93 and a 12 month high of $348.67. The firm has a market cap of $10.42 billion, a price-to-earnings ratio of 262.03 and a beta of 0.54. The company has a quick ratio of 3.41, a current ratio of 5.99 and a debt-to-equity ratio of 0.02. The company’s 50 day moving average is $249.62 and its 200-day moving average is $241.78.

Insider Activity

In other news, EVP Johanna Roberts sold 600 shares of Penumbra stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $226.42, for a total value of $135,852.00. Following the transaction, the executive vice president now owns 62,251 shares of the company’s stock, valued at $14,094,871.42. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, EVP Johanna Roberts sold 600 shares of the business’s stock in a transaction on Friday, December 1st. The shares were sold at an average price of $226.42, for a total transaction of $135,852.00. Following the transaction, the executive vice president now owns 62,251 shares of the company’s stock, valued at $14,094,871.42. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Bridget O’rourke sold 150 shares of the business’s stock in a transaction on Thursday, November 30th. The stock was sold at an average price of $226.41, for a total transaction of $33,961.50. Following the transaction, the director now directly owns 4,214 shares in the company, valued at approximately $954,091.74. The disclosure for this sale can be found here. Insiders have sold a total of 835 shares of company stock valued at $190,866 over the last 90 days. 5.30% of the stock is currently owned by company insiders.

Penumbra Profile

(Free Report)

Penumbra, Inc, together with its subsidiairies, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, SENDit, and PX SLIM brands.

Read More

Want to see what other hedge funds are holding PEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Penumbra, Inc. (NYSE:PENFree Report).

Institutional Ownership by Quarter for Penumbra (NYSE:PEN)

Receive News & Ratings for Penumbra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Penumbra and related companies with MarketBeat.com's FREE daily email newsletter.